236 related articles for article (PubMed ID: 25623578)
21. Reporting Quality of Studies Developing and Validating Melanoma Prediction Models: An Assessment Based on the TRIPOD Statement.
Kaiser I; Diehl K; Heppt MV; Mathes S; Pfahlberg AB; Steeb T; Uter W; Gefeller O
Healthcare (Basel); 2022 Jan; 10(2):. PubMed ID: 35206853
[TBL] [Abstract][Full Text] [Related]
22. Uniformity in measuring adherence to reporting guidelines: the example of TRIPOD for assessing completeness of reporting of prediction model studies.
Heus P; Damen JAAG; Pajouheshnia R; Scholten RJPM; Reitsma JB; Collins GS; Altman DG; Moons KGM; Hooft L
BMJ Open; 2019 Apr; 9(4):e025611. PubMed ID: 31023756
[TBL] [Abstract][Full Text] [Related]
23. TRIPOD statement: a preliminary pre-post analysis of reporting and methods of prediction models.
Zamanipoor Najafabadi AH; Ramspek CL; Dekker FW; Heus P; Hooft L; Moons KGM; Peul WC; Collins GS; Steyerberg EW; van Diepen M
BMJ Open; 2020 Sep; 10(9):e041537. PubMed ID: 32948578
[TBL] [Abstract][Full Text] [Related]
24. Prediction models in gynaecology: Transparent reporting needed for clinical application.
Gelderblom ME; Stevens KYR; Houterman S; Weyers S; Schoot BC
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():190-202. PubMed ID: 34509878
[TBL] [Abstract][Full Text] [Related]
25. Bias and Reporting Quality of Clinical Prognostic Models for Idiopathic Pulmonary Fibrosis: A Cross-Sectional Study.
Di J; Li X; Yang J; Li L; Yu X
Risk Manag Healthc Policy; 2022; 15():1189-1201. PubMed ID: 35702399
[TBL] [Abstract][Full Text] [Related]
26. The reporting of prognostic prediction models for obstetric care was poor: a cross-sectional survey of 10-year publications.
Liu C; Qi Y; Liu X; Chen M; Xiong Y; Huang S; Zou K; Tan J; Sun X
BMC Med Res Methodol; 2023 Jan; 23(1):9. PubMed ID: 36635634
[TBL] [Abstract][Full Text] [Related]
27. Quality and transparency of reporting derivation and validation prognostic studies of recurrent stroke in patients with TIA and minor stroke: a systematic review.
Abdulaziz KE; Perry JJ; Yadav K; Dowlatshahi D; Stiell IG; Wells GA; Taljaard M
Diagn Progn Res; 2022 May; 6(1):9. PubMed ID: 35585563
[TBL] [Abstract][Full Text] [Related]
28. Increased endorsement of TRIPOD and other reporting guidelines by high impact factor journals: survey of instructions to authors.
Heus P; Idema DL; Kruithof E; Damen JAAG; Verhoef-Jurgens MS; Reitsma JB; Moons KGM; Hooft L
J Clin Epidemiol; 2024 Jan; 165():111188. PubMed ID: 37852392
[TBL] [Abstract][Full Text] [Related]
29. A systematic review of the quality of clinical prediction models in in vitro fertilisation.
Ratna MB; Bhattacharya S; Abdulrahim B; McLernon DJ
Hum Reprod; 2020 Jan; 35(1):100-116. PubMed ID: 31960915
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the quality of reporting of melanoma prediction models.
Jiang MY; Dragnev NC; Wong SL
Surgery; 2020 Jul; 168(1):173-177. PubMed ID: 32448593
[TBL] [Abstract][Full Text] [Related]
31. Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.
Petrou S; Rivero-Arias O; Dakin H; Longworth L; Oppe M; Froud R; Gray A
Health Qual Life Outcomes; 2015 Aug; 13():106. PubMed ID: 26232268
[TBL] [Abstract][Full Text] [Related]
32. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
Int J Surg; 2012; 10(1):28-55. PubMed ID: 22036893
[TBL] [Abstract][Full Text] [Related]
33. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.
Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
J Clin Epidemiol; 2010 Aug; 63(8):e1-37. PubMed ID: 20346624
[TBL] [Abstract][Full Text] [Related]
34. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
[TBL] [Abstract][Full Text] [Related]
35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
36. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.
Cohen JF; Korevaar DA; Altman DG; Bruns DE; Gatsonis CA; Hooft L; Irwig L; Levine D; Reitsma JB; de Vet HC; Bossuyt PM
BMJ Open; 2016 Nov; 6(11):e012799. PubMed ID: 28137831
[TBL] [Abstract][Full Text] [Related]
37. Standardization of risk prediction model reporting in cancer-associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy.
Sanfilippo KM; Wang TF; Carrier M; Falanga A; Gage BF; Khorana AA; Maraveyas A; Soff GA; Wells PS; Zwicker JI
J Thromb Haemost; 2022 Aug; 20(8):1920-1927. PubMed ID: 35635332
[TBL] [Abstract][Full Text] [Related]
38. Reporting of coronavirus disease 2019 prognostic models: the transparent reporting of a multivariable prediction model for individual prognosis or diagnosis statement.
Yang L; Wang Q; Cui T; Huang J; Shi N; Jin H
Ann Transl Med; 2021 Mar; 9(5):421. PubMed ID: 33842642
[TBL] [Abstract][Full Text] [Related]
39. Prognostic models for predicting relapse or recurrence of major depressive disorder in adults.
Moriarty AS; Meader N; Snell KI; Riley RD; Paton LW; Chew-Graham CA; Gilbody S; Churchill R; Phillips RS; Ali S; McMillan D
Cochrane Database Syst Rev; 2021 May; 5(5):CD013491. PubMed ID: 33956992
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
